Cargando…
Small Molecular Antimicrobial Ligands of YspD are Potential Therapeutic Agents Against Yersinia enterocolitica Infection
YspD is a hydrophilic translocator forming the platform for assemblage of functional translocon. Exposure to the extra-cellular milieu makes YspD a potential therapeutic target. DoGSiteScorer predicted best druggable pocket (P0) within YspD, encompassing predominantly the C-terminal helical bundles...
Autores principales: | , , , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Springer India
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9801161/ https://www.ncbi.nlm.nih.gov/pubmed/36597505 http://dx.doi.org/10.1007/s40011-022-01443-2 |
_version_ | 1784861442118254592 |
---|---|
author | Mandal, Debjani Mukherjee, Raktim Ghosh, Shrabana Bachhawat, Tamanna Dutta, Sneha Das, Urmisha Basu, Abhishek |
author_facet | Mandal, Debjani Mukherjee, Raktim Ghosh, Shrabana Bachhawat, Tamanna Dutta, Sneha Das, Urmisha Basu, Abhishek |
author_sort | Mandal, Debjani |
collection | PubMed |
description | YspD is a hydrophilic translocator forming the platform for assemblage of functional translocon. Exposure to the extra-cellular milieu makes YspD a potential therapeutic target. DoGSiteScorer predicted best druggable pocket (P0) within YspD, encompassing predominantly the C-terminal helical bundles and the long helices-9 & 5. COACH metaserver also identified ligand binding residues within the aforementioned druggable pocket mapping to helix-9. Amino acids of helix-9 are involved in oligomerization of YspD. Interaction of helix-9 and parts of C-terminal of YspD with hydrophobic translocator protein (YspB), is essential for translocation of bacterial effectors to initiate an infection. Helices-9 & 5 form an intramolecular coiled-coil structure, required for protein–protein interaction. Targeting intramolecular coiled-coil and parts of C-terminal would be important for functional inactivation of YspD. Solvent exposed surface in YspD, particularly in P0, enhances its accessibility to ligands. Nine small molecular inhibitors of TIIISS were identified and retrieved from ZINC15 database (drug-library) as putative drug candidates. Molecular docking of potential ligands with P0 was done using SwissDock server and Achilles Blind Docking server. Considering the “Significance” threshold of binding score and region of interaction, Salicylidene Acyl Hydrazide derivatives (INP0400) and Phenoxyacetamide derivative (MBX1641) were found to bind effectively with YspD. These potential ligands interact with functional domains of YspD including parts of C-terminal and the intramolecular coiled-coil, which may affect the oligomerization of YspD and disrupt the interaction of YspD with YspB, inhibiting formation of functional translocon. The identified small molecular antimicrobial ligands of YspD could be tested in vivo to attenuate Y. enterocolitica infection by deregulation of Ysa-Ysp TIIISS. SUPPLEMENTARY INFORMATION: The online version contains supplementary material available at 10.1007/s40011-022-01443-2. |
format | Online Article Text |
id | pubmed-9801161 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2022 |
publisher | Springer India |
record_format | MEDLINE/PubMed |
spelling | pubmed-98011612022-12-30 Small Molecular Antimicrobial Ligands of YspD are Potential Therapeutic Agents Against Yersinia enterocolitica Infection Mandal, Debjani Mukherjee, Raktim Ghosh, Shrabana Bachhawat, Tamanna Dutta, Sneha Das, Urmisha Basu, Abhishek Proc Natl Acad Sci India Sect B Biol Sci Research Article YspD is a hydrophilic translocator forming the platform for assemblage of functional translocon. Exposure to the extra-cellular milieu makes YspD a potential therapeutic target. DoGSiteScorer predicted best druggable pocket (P0) within YspD, encompassing predominantly the C-terminal helical bundles and the long helices-9 & 5. COACH metaserver also identified ligand binding residues within the aforementioned druggable pocket mapping to helix-9. Amino acids of helix-9 are involved in oligomerization of YspD. Interaction of helix-9 and parts of C-terminal of YspD with hydrophobic translocator protein (YspB), is essential for translocation of bacterial effectors to initiate an infection. Helices-9 & 5 form an intramolecular coiled-coil structure, required for protein–protein interaction. Targeting intramolecular coiled-coil and parts of C-terminal would be important for functional inactivation of YspD. Solvent exposed surface in YspD, particularly in P0, enhances its accessibility to ligands. Nine small molecular inhibitors of TIIISS were identified and retrieved from ZINC15 database (drug-library) as putative drug candidates. Molecular docking of potential ligands with P0 was done using SwissDock server and Achilles Blind Docking server. Considering the “Significance” threshold of binding score and region of interaction, Salicylidene Acyl Hydrazide derivatives (INP0400) and Phenoxyacetamide derivative (MBX1641) were found to bind effectively with YspD. These potential ligands interact with functional domains of YspD including parts of C-terminal and the intramolecular coiled-coil, which may affect the oligomerization of YspD and disrupt the interaction of YspD with YspB, inhibiting formation of functional translocon. The identified small molecular antimicrobial ligands of YspD could be tested in vivo to attenuate Y. enterocolitica infection by deregulation of Ysa-Ysp TIIISS. SUPPLEMENTARY INFORMATION: The online version contains supplementary material available at 10.1007/s40011-022-01443-2. Springer India 2022-12-30 2023 /pmc/articles/PMC9801161/ /pubmed/36597505 http://dx.doi.org/10.1007/s40011-022-01443-2 Text en © The Author(s), under exclusive licence to The National Academy of Sciences, India 2022. Springer Nature or its licensor (e.g. a society or other partner) holds exclusive rights to this article under a publishing agreement with the author(s) or other rightsholder(s); author self-archiving of the accepted manuscript version of this article is solely governed by the terms of such publishing agreement and applicable law. This article is made available via the PMC Open Access Subset for unrestricted research re-use and secondary analysis in any form or by any means with acknowledgement of the original source. These permissions are granted for the duration of the World Health Organization (WHO) declaration of COVID-19 as a global pandemic. |
spellingShingle | Research Article Mandal, Debjani Mukherjee, Raktim Ghosh, Shrabana Bachhawat, Tamanna Dutta, Sneha Das, Urmisha Basu, Abhishek Small Molecular Antimicrobial Ligands of YspD are Potential Therapeutic Agents Against Yersinia enterocolitica Infection |
title | Small Molecular Antimicrobial Ligands of YspD are Potential Therapeutic Agents Against Yersinia enterocolitica Infection |
title_full | Small Molecular Antimicrobial Ligands of YspD are Potential Therapeutic Agents Against Yersinia enterocolitica Infection |
title_fullStr | Small Molecular Antimicrobial Ligands of YspD are Potential Therapeutic Agents Against Yersinia enterocolitica Infection |
title_full_unstemmed | Small Molecular Antimicrobial Ligands of YspD are Potential Therapeutic Agents Against Yersinia enterocolitica Infection |
title_short | Small Molecular Antimicrobial Ligands of YspD are Potential Therapeutic Agents Against Yersinia enterocolitica Infection |
title_sort | small molecular antimicrobial ligands of yspd are potential therapeutic agents against yersinia enterocolitica infection |
topic | Research Article |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9801161/ https://www.ncbi.nlm.nih.gov/pubmed/36597505 http://dx.doi.org/10.1007/s40011-022-01443-2 |
work_keys_str_mv | AT mandaldebjani smallmolecularantimicrobialligandsofyspdarepotentialtherapeuticagentsagainstyersiniaenterocoliticainfection AT mukherjeeraktim smallmolecularantimicrobialligandsofyspdarepotentialtherapeuticagentsagainstyersiniaenterocoliticainfection AT ghoshshrabana smallmolecularantimicrobialligandsofyspdarepotentialtherapeuticagentsagainstyersiniaenterocoliticainfection AT bachhawattamanna smallmolecularantimicrobialligandsofyspdarepotentialtherapeuticagentsagainstyersiniaenterocoliticainfection AT duttasneha smallmolecularantimicrobialligandsofyspdarepotentialtherapeuticagentsagainstyersiniaenterocoliticainfection AT dasurmisha smallmolecularantimicrobialligandsofyspdarepotentialtherapeuticagentsagainstyersiniaenterocoliticainfection AT basuabhishek smallmolecularantimicrobialligandsofyspdarepotentialtherapeuticagentsagainstyersiniaenterocoliticainfection |